X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1431) 1431
Book Review (307) 307
Newsletter (243) 243
Publication (132) 132
Book Chapter (11) 11
Newspaper Article (7) 7
Conference Proceeding (4) 4
Dissertation (4) 4
Reference (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
panitumumab (1622) 1622
index medicus (918) 918
cetuximab (892) 892
humans (840) 840
colorectal cancer (833) 833
oncology (768) 768
chemotherapy (567) 567
cancer (528) 528
colorectal neoplasms - drug therapy (482) 482
metastasis (408) 408
female (367) 367
care and treatment (363) 363
1st-line treatment (355) 355
research (352) 352
male (351) 351
colorectal neoplasms - genetics (349) 349
mutation (330) 330
colorectal neoplasms - pathology (327) 327
middle aged (316) 316
kras (310) 310
aged (294) 294
bevacizumab (293) 293
fluorouracil (293) 293
antibodies, monoclonal - therapeutic use (288) 288
epidermal growth factor (271) 271
antineoplastic agents - therapeutic use (258) 258
receptor, epidermal growth factor - antagonists & inhibitors (245) 245
egfr (242) 242
ras proteins - genetics (240) 240
adult (235) 235
leucovorin (227) 227
antineoplastic combined chemotherapy protocols - therapeutic use (224) 224
growth-factor receptor (212) 212
oxaliplatin (212) 212
proto-oncogene proteins p21 (202) 202
proto-oncogene proteins - genetics (201) 201
metastatic colorectal-cancer (193) 193
monoclonal antibodies (191) 191
metastatic colorectal cancer (190) 190
treatment outcome (190) 190
open-label (185) 185
drug therapy (184) 184
neoplasm metastasis (183) 183
therapy (179) 179
phase-iii trial (178) 178
analysis (174) 174
genetic aspects (171) 171
aged, 80 and over (161) 161
tumors (161) 161
antibodies, monoclonal - administration & dosage (160) 160
disease-free survival (152) 152
oncology, experimental (148) 148
pharmacology & pharmacy (148) 148
prognosis (147) 147
antibodies, monoclonal, humanized (146) 146
cetuximab plus irinotecan (146) 146
health aspects (144) 144
irinotecan (141) 141
medicine & public health (140) 140
proto-oncogene proteins b-raf - genetics (140) 140
survival (140) 140
braf (137) 137
immunotherapy (127) 127
antibodies, monoclonal - adverse effects (115) 115
clinical trials (114) 114
cancer therapies (111) 111
cancer patients (109) 109
ras mutations (108) 108
trial (108) 108
digestive system diseases (107) 107
animals (106) 106
epidermal growth factor receptor (106) 106
phase-iii (106) 106
hematology, oncology and palliative medicine (105) 105
patients (103) 103
antineoplastic agents (102) 102
colorectal carcinoma (101) 101
colorectal neoplasms - mortality (101) 101
expression (100) 100
antimitotic agents (94) 94
receptor, epidermal growth factor - metabolism (94) 94
monoclonal-antibody (93) 93
efficacy (92) 92
camptothecin - analogs & derivatives (91) 91
reports (91) 91
antineoplastic agents - pharmacology (88) 88
gene mutations (88) 88
metastases (87) 87
antibodies, monoclonal - pharmacology (86) 86
antineoplastic agents - adverse effects (86) 86
colon cancer (86) 86
development and progression (83) 83
colon-cancer (82) 82
cell lung-cancer (81) 81
colorectal neoplasms - metabolism (81) 81
erlotinib (81) 81
gefitinib (81) 81
cancer research (80) 80
surgery (80) 80
biomarkers (79) 79
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1614) 1614
French (28) 28
German (19) 19
Spanish (14) 14
Japanese (8) 8
Czech (4) 4
Russian (4) 4
Hungarian (3) 3
Korean (3) 3
Chinese (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2018, Volume 81, Issue 1, pp. 179 - 182
Data on panitumumab dosing in cancer patients with renal insufficiency are lacking. Here, we report a 63-year-old metastatic colorectal cancer patient with... 
Renal insufficiency | Medicine & Public Health | Panitumumab | Colorectal cancer | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacokinetics | THERAPY | SOLID TUMORS | ONCOLOGY | PHARMACOLOGY & PHARMACY | DYSFUNCTION | Antineoplastic Agents, Immunological - administration & dosage | Antineoplastic Agents, Immunological - pharmacokinetics | Glomerular Filtration Rate | Area Under Curve | Humans | Middle Aged | Half-Life | Male | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - physiopathology | Dose-Response Relationship, Drug | Renal Insufficiency, Chronic - metabolism | Panitumumab - administration & dosage | Antineoplastic Agents, Immunological - adverse effects | Panitumumab - pharmacokinetics | Animals | Antineoplastic Agents, Immunological - therapeutic use | Colorectal Neoplasms - drug therapy | Panitumumab - therapeutic use | Colorectal Neoplasms - complications | Panitumumab - adverse effects | Antimitotic agents | Medical research | Safety and security measures | Chronic kidney failure | Pharmacy | Medicine, Experimental | Drugstores | Metastasis | Antineoplastic agents | Renal function | Approximation | Colorectal carcinoma | Radioactive half-life | Pharmacology | Dosage | Patients | Glomerular filtration rate | Metastases | Renal failure | Cancer | Kidney transplantation | Index Medicus | Original
Journal Article
Nature, ISSN 0028-0836, 06/2012, Volume 486, Issue 7404, pp. 532 - 536
Journal Article
Japanese Journal of Cancer and Chemotherapy, ISSN 0385-0684, 10/2018, Volume 45, Issue 10, pp. 1435 - 1440
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 13, pp. 1704 - 1713
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 01/2015, Volume 372, Issue 3, pp. 291 - 292
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 02/2019, Volume 16, Issue 2, pp. 768 - 778
Our aim was to evaluate the effectiveness and normal tissue toxicity of radioimmunotherapy (RIT) of s.c. PANC-1 human pancreatic cancer (PnCa) xenografts in... 
Lu | radioimmunotherapy | panitumumab | EGFR | metal-chelating polymers
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 08/2017, Volume 28, Issue 8, pp. 1862 - 1868
Background: Previous studies have reported the prognostic impact of primary tumor sidedness in metastatic colorectal cancer (mCRC) and its influence on... 
First-line | RAS wild-type | Tumor sidedness | Panitumumab | Metastatic colorectal cancer | LOCATION | LEUCOVORIN | METAANALYSIS | MCRC | tumor sidedness | BEVACIZUMAB | PROXIMAL COLON | panitumumab | FLUOROURACIL | COLON-CANCER | CETUXIMAB | ONCOLOGY | FREE SURVIVAL PFS | first-line | metastatic colorectal cancer | Index Medicus | Original
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 06/2019, Volume 46, Issue 6, pp. e221 - e222
Journal Article
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 03/2018, Volume 15, Issue 3, pp. 1150 - 1159
A metal-chelating polymer (MCP) with a polyglutamide (PGlu) backbone presenting on average 13 DOTA (tetraazacyclododecane-1,4,7,10-tetraacetic acid) chelators... 
indium-111 | pancreatic cancer | radioimmunotherapy | metal-chelating polymers | lutetium-177 | panitumumab | imaging
Journal Article